2010
DOI: 10.1111/j.1440-1797.2009.01245.x
|View full text |Cite
|
Sign up to set email alerts
|

Role of distal protection devices

Abstract: Date written: November 2008 Final submission: August 2009

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 27 publications
0
3
0
Order By: Relevance
“…Patients with baseline advanced CKD (GFR < 30 mL/min per 1.73 m 2 ) warrant additional attention as they have additional risks of CIN and life‐threatening/major bleeding because of intrinsic platelet dysfunction. Technical improvement in TAVI with smaller delivery system and the use of embolic protection device may reduce the incidence of embolic event and AKI 22,23 . Recent data suggest a correlation between the systemic inflammatory response syndrome characterized by elevated post‐procedural leucocyte count and AKI 8,11 .…”
Section: Discussionmentioning
confidence: 99%
“…Patients with baseline advanced CKD (GFR < 30 mL/min per 1.73 m 2 ) warrant additional attention as they have additional risks of CIN and life‐threatening/major bleeding because of intrinsic platelet dysfunction. Technical improvement in TAVI with smaller delivery system and the use of embolic protection device may reduce the incidence of embolic event and AKI 22,23 . Recent data suggest a correlation between the systemic inflammatory response syndrome characterized by elevated post‐procedural leucocyte count and AKI 8,11 .…”
Section: Discussionmentioning
confidence: 99%
“…123 Technical improvement in TAVR through the use of smaller delivery systems and embolic protection devices could also be helpful. 124 Overall, as in the case EVAR, complex protocols may be needed to fully delineate the optimal prevention strategies for AKI in patients undergoing TAVR. However, the first step for future research could be investigating strategies that were tested in other endovascular procedures, i.e.…”
mentioning
confidence: 99%
“…The SpiderFX (Medtronic) The Mo.Ma Ultra Proximal Cerebral Protection Device (Medtronic) Structural be secondary to inflammation, and microinfarction secondary to the embolisation of atheromatous debris. A review of distal protection devices for RAS 'suggested' the use of EPDs when performing renal artery angioplasty 41. EPDs can be technically challenging to use when treating RAS due to the configuration of the renal artery.…”
mentioning
confidence: 99%